Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -4 of 4 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 6/6/2008 First Published: 6/23/2004


1.		Phase IV Randomized Study of Rasburicase Alone Versus Rasburicase and Allopurinol Versus Allopurinol Alone in Patients With Leukemia, Lymphoma, or Solid Tumor Malignancy at Risk for Hyperuricemia and Tumor Lysis Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Closed				18 and over				Pharmaceutical / Industry				PROLOGUE-EFC4978 UCLA-0403071-01, NCT00230178

Last Modified: 7/11/2007 First Published: 6/23/2004


2.		Phase IV Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Closed				Any age				Pharmaceutical / Industry				PROLOGUE-EFC5339 SANOFI-EFC5339, UCLA-0403072-01, NCT00086918


3.		Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				Other				2006-0298 NCT00360438

Last Modified: 3/1/1998


4.		Phase II Study of SR 29142 for Hyperuricemia in Patients with Leukemias and Lymphomas (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				21 and under				NCI				POG-9680

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute